(Q54621891)
Statements
A phase II double-blind study to investigate efficacy and safety of two doses of the triple angiokinase inhibitor BIBF 1120 in patients with relapsed advanced non-small-cell lung cancer. (English)
1 reference
M Reck
1 reference
R Kaiser
1 reference
C Eschbach
1 reference
M Stefanic
1 reference
J Love
1 reference
U Gatzemeier
1 reference
P Stopfer
1 reference
J von Pawel
1 reference
6 January 2011
1 reference
22
1 reference
6
1 reference
1374-1381
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference